A company still losing money with shrinking sales, with high risk. Institutions are adding.
Facts from SEC filings, not a recommendation.
Last 12 months: $34.2M, down 33% from the 12 months before. Over 5 years, sales shrank about 18% a year.
Price chart by TradingView.
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions added 29.3% to their holdings. 9 bought, 7 sold. 2 quarters of net buying in a row.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
150,602 shares
301,205 shares
2,456,100 shares at $4.89 avg ($0.38 to $6.70) · $12.0M
1,750,000 shares at $2.00 · $3.5M
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page